The “A2” rating assignment is based on several factors, including Palomar Health’s ongoing growth in assessed valuation and improved financial operations.
The outlook is stable, reflecting Palomar Health’s improved operating performance and liquidity levels.
More articles on healthcare finance:
Chinese billionaire ups stake in CHS for $31.9M
Fazzi to create 300 jobs in Ireland with new healthcare services and coding company
Health management company launches RCM subsidiary